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Percutaneous transhepatic cholecystic drainage (PTCCD) with percutaneous transhepatic
cholecystoscopic lithotomy (PTCCSL) were performed in 53 patients with acute
cholecystitis caused by gallbladder stones and studied stone removal rates, complications,
endoscopic findings, and stone recurrence. The stones were successfully removed in 96%
of the patients, and there were no serious complications. The coexistence of cancer was
confirmed in three patients, and all cases were accurately diagnosed on the basis of
ultrasonographic, endoscopic, and biopsy findings. The mean duration of follow-up after
stone removal was 42 months, and the stone recurrence rate was 2.5%. Among the 39
patients followed up for at least 1 year, the gallbladder could be preserved with no
evidence of sludge in patients in whom drainage was performed early after the onset of
symptoms, those with a normal gallbladder after PTCCSL, and those with normal
gallbladder contractility after PTCCSL. Sludge was present in patients with evidence of
extensive areas of yellowish white fibers on percutaneous transhepatic cholecystoscopy. If
instituted early after the onset of symptoms, PTCCD combined with PTCCSL was
considered useful in the treatment of patients with acute cholecystitis associated with
gallbladder stones.
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INTRODUCTION
Percutaneous transhepatic cholecystic drainage
(PTCCD) is useful in the treatment of acute
cholecystitis caused by gallbladder stones [1]. After
PTCCD, percutaneous transhepatic cholecystos-
copy (PTCCS), via the fistula used for drainage,
with percutaneous transhepatic cholecystoscopic
lithotomy (PTCCSL) has been reported to be a
useful procedure in elderly patients and high-risk
patients with serious underlying disease [1,2].
However, experience with PTCCSL in patients
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with acute .cholecystitis and gallbladder stones is
limited, and no study has evaluated the safety
and efficacy of this procedure in detail. To
evaluate the potential of PTCCSL as a procedure
for lithotomy and to assess its ability to preserve
gallbladder function in patients with acute chole-
cystitis, this study was undertaken.
SUBJECTS AND METHODS
The study group comprised 53 patients with acute
cholecystitis who underwent lithotomy byPTCCSL
between October 1987 and February 1994. All
patients presented with spontaneous pain and
tenderness of the right hypochondrium or epigas-
trium and had a fever of at least 37C and leuko-
cytosis, as defined by a leukocyte count of 9 103
cells/tl or more. Ultrasonographic examination
revealed evidence of an enlarged gallbladder,
thickening of the gallbladder wall, or the presence
of sludge inside the gallbladder. PTCCD was
performed for a diagnosis of acute cholecystitis
caused by gallbladder stones. The patients were
given a detailed explanation of the procedure be-
fore PTCCD and PTCCSL, and informed consent
was obtained before performing either procedure.
An 18 G needle was used for PTCCD. In princi-
ple, the needle was inserted transhepatically via
the gallbladder bed, under ultrasonographic guid-
ance. PTCCD was performed with the use of a
8 Fr drainage tube equipped with a balloon. The
fistula was dilatated by insertion of a 16 or 18 Fr
tube 3-7 days after insertion of the 8 Fr tube, or
a 16 or 18 Fr tube was inserted on the same day
instead of the 8 Fr drainage tube. Dilatation was
performed with the use of a coaxial dilator (PTC-
Ichikawa-A-16 or PTC-Ichikawa-A-18, Cook Co.,
Ltd., Bloomington, USA) as described by Ichikawa
et al. [3]. PTCCS was performed week after
fistula dilatation. For endoscopy, models CHF-
P10, CHF-P20Q, and CHF-T20 endoscopes
(Olympus Optical Co., Ltd., Tokyo, Japan) were
used. The gallstones were crushed with an electro-
hydraulic lithotriptor (EHL), and the stone frag-
ments were removed with a basket catheter or a
lithotomy forceps under endoscopic guidance.
About 3 days after stone removal, PTCCS was
performed to confirm that no stones remained.
The absence of stone fragments was confirmed by
conventional observation and after the applica-
tion of 0.5% methylene blue solution. Endoscopic
examinations were able to be performed in 49
patients; they were not possible in 3 patients with
concurrent gallbladder carcinoma and in 1 patient
in whom bleeding precluded observation of the
mucosa. The basic pattern of the gallbladder
mucosa, defined as that accounting for two-thirds
of the entire mucosal surface, was classified as
reticular (Fig. 1), granular (Fig. 2), flat (Fig. 3),
or deteriorated pattern (DET) (Fig. 4).
In 40 patients the presence or absence of stone
recurrence or sludge accumulation was confirmed
by ultrasonography 4 weeks, and more year
after removal of the biliary drainage tube. Fol-
low-up examinations were not possible in 13
patients: 3 because of gallbladder carcinoma, 4
who underwent cholecystectomy at the time of
laparotomy due to another disease, and 6 who were
lost to follow-up after PTCCSL. At follow-up,
the maximum transverse area of the gallblad-
der was estimated by the trace technique before
and 15min after the intramuscular injection of
0.2mg/m
2 ceruletide diethylamine. Gallbladder
contractility was calculated by dividing the trans-
verse area of the gallbladder after intramuscular
injection by that before intramuscular injection.
The patients were also divided into those with
evidence of gallbladder sludge at the time of
follow-up (sludge-positive group) and those with
no evidence of gallbladder sludge (sludge-negative
group) to study if PTCCSL was effective in
preventing stone recurrence. The time from the
onset of acute cholecystitis was calculated from
the day on which fever or abdominal pain devel-
oped, as ascertained by interview. Stone size was
measured on PTCCD films taken before lithot-
omy. The stones removed at the time of PTCCSL
were analyzed to determine their composition. In
principle, after PTCCSL the patients were given
600mg/day of UDCA to prevent stone recur-
rence. The chi-square test was used for statisticalMANAGEMENT OF ACUTE CHOLECYSTITIS 21
FIGURE Endoscopic findings after dyeing with methylene-blue solution. There was a reticular structure on the mucosa,
associated with mild changes suggesting acute cholecystitis.
FIGURE 2 Endoscopic findings after dyeing with methylene-blue solution. The mucosa had a homogenous, finely granular
appearance, without fusion between the granules.22 S. OHASHI
FIGURE 3 Endoscopic findings. The mucosa had lost its reticular structure and resembled atrophic gastritis.
FIGURE 4 Endoscopic findings in a case of necrotic cholecystitis. Rough deteriorated yellowish white fibers covered the inside
of the lumen, which had reddish columnar mucosa with severe mucosal necrosis. The distensibility of the wall was reduced.MANAGEMENT OF ACUTE CHOLECYSTITIS 23
analysis. P values of less than 0.05 were consid-
ered to indicate statistical significance.
RESULTS
1. Classification of Stones and Clinical Signs
and Symptoms of Acute Cholecystitis
Twenty-two men and 31 women with a mean
age of 64.2 years (range, 32-89) were studied.
Stones were analyzed in 49 of the 53 patients.
Twenty-nine patients had cholesterol stones, and
20 had bilirubin stones. Before lithotomy the
mean maximum stone diameter was 14.4mm; 36
patients (68%) had stones with maximum dia-
meters of 10mm or more. The mean period from
onset of symptoms to PTCCD was 5.1 days, and
the mean period from admission until PTCCD
was 2.1 days. A total of 44 patients (83%) under-
went PTCCD within the first hospital day. Before
PTCCD all patients had abdominal pain, 86%
had fever, and 85% had leukocytosis. Abdominal
pain resolved promptly after PTCCD, followed
by the resolution of fever and leukocytosis, in
that order. All signs and symptoms of inflamma-
tion disappeared within 5 days, and the clinical
condition of all patients improved.
2. Outcome of PTCCSL
Lithotomy by PTCCSL was performed from one
to six times (mean, 2.5 times per patient). Forty-
two patients underwent PTCCSL three times or
less, and the stones could be completely pulver-
ized in 51 patients (96%). Lithotripsy was not
possible in 2 patients because of bleeding (1) or
cystic duct injury (1). In this latter patient, a
small amount of contrast media had leaked out
from the cystic duct on imaging examinations
during PTCCSL. Although this case could be
managed conservatively, cholecystectomy was
performed at the patient’s request. The patient
with gallbladder bleeding had renal failure asso-
ciated with a hemorrhagic diathesis. Exudative
bleeding occurred, and hemostasis was performed
conservatively. There were no other serious com-
plications.
3. PTCCS Findings after Lithotripsy
The basic pattern of the mucosa was classifiable
in 49 patients. It was reticular in 28 patients
(58%), granular in 11 patients (23.1%), flat in 6
patients (12.6%), and DET in 4 patients (6.3%).
In the DET cases, the lumen appeared to contain
yellowish white fibrous material, the distensibility
of the wall was reduced.
4. Recurrent Stones after PTCCSL
Among 40 patients in whom the gallbladder was
preserved who were able to be followed up, new
stone occurred in patient (2.5%). She had
bilirubin stones at the initial episode and at
recurrence. Gallbladder contractility decreased to
73% after the initial session of PTCCSL. Stone
recurrence was confirmed on abdominal ultraso-
nography 5 months after lithotomy. The patient
was asymptomatic and followed up without any
treatment. After 10 months the patient experi-
enced abdominal pain, and cholecystitis devel-
oped. PTCCSL was repeated at the patient’s
request. Subsequently, there have been no signs
or symptoms of recurrence.
5. Sludge at Follow-up
The long-term possibility of stone recurrence was
forecast on the basis of the presence or absence of
sludge.
(1) Clinical Demographic Characteristics
(Table I)
The follow-up period was 46 months in the
sludge-positive group and 40 months in the
sludge-negative group. This difference was not
significant. There were also no distinct differences
in male:female ratio, mean age, stone composi-
tion, or maximal stone diameter. There was a24 S. OHASHI
TABLE Clinical demographic characteristics
Sludge Positive groupn_-5 Negative groupn= 24
Mean duration of follow up (month) 46 + 15 40 + 14
Sex (male female) 5 10 10 14
Stone
Component (CH: BI) 7 8 12 12
Mean maximum in diameter (mm) 13.1 + 8.0 15.5 + 8.8
Choleretic agent after PTCCSL 11/15 23/24
CH: cholesterol stone, BI: bilirubinate stone, PTCCSL: percutaneous transhepatic cholecystoscopic
lithotomy.
TABLE II Clinical signs, symptoms and course
Sludge Positive group 15 Negative group 24
Before PTCCD
Temperature (C) 37.3 + 0.5 37.8 +/- 1.0
Leukocyte count 12700+ 5900 14300+ 6500
Mean period from onset until PTCCD (day) 10.5 -+- 12.3" 2.56 + 2.57*
Mean period until improvement
after PTCCD (day)
Abdominal pain 0.4 +/- 0.8 0.1 +/- 0.3
Fever 1.5 + 1.3 1.2+ 1.2
Leukocytosis 6.1 -+- 5.4 5.0+ 5.9
Mean session of PTCCSL 2.6 + 1.6 2.3 +/- 1.1
PTCCD: percutaneous transhepatic cholecystic drainage, PTCCSL: percutaneous transhepatic chole-
cystoscopic lithotomy.
*p<0.05.
trend toward a lower proportion of patients
receiving choleretic agents in the sludge-positive
group, but the difference was not statistically
significant. The clinical demographic characteris-
tics of the patients in the sludge-positive group
were thus similar to those in the sludge-negative
group.
Clinical Signs and Symptoms
and Course (Table H)
There were no differences between the groups in
body temperature or leukocyte count before
PTCCD, and the inflammatory response was
considered similar. The mean period from onset
until PTCCD was 2.5 days in the sludge-negative
group, as compared with more than 10 days in
the sludge-positive group. Clearly, PTCCD was
started earlier in the sludge-negative group. There
was no distinct difference between the groups in
the improvement of symptoms after PTCCD. The
mean number of attempts at PTCCSL was 2.6
times in the sludge-positive group and 2.3 times
in the sludge-negative group.
(3) Ultrasonographic Findings (Table III)
Before PTCCD evidence of thickening of the
gallbladder wall was found in all patients in both
groups. A three-layered structure of the wall was
present in 79% and 73% and a hypoechoic area
around the gallbladder in 20% and 25% of the
sludge-negative group and the sludge-positive
group, respectively. These differences were not
significant.
The cross-sectional of the gallbladder 4 weeks
after PTCCSL was normal in the sludge-negative
group, while it decreased to a mean value of
628mm
3 in the sludge-positive group. This dif-
ference was significant. The mean rate ofMANAGEMENT OF ACUTE CHOLECYSTITIS 25
TABLE III Ultrasonographic findings of gallbladder
Sludge Positive groupn_-15 Negative groupn= 24
Before PTCCD
Thickening of wall (%) 15 (100) 24 (100)
Three layered structure 11 (73) 19 (79)
Sludge 12 (80) 18 (75)
HEA 3 (20) 6 (25)
After PTCCSL
Mean thickening of wall (mm) 4.1 + 1.7 3.4+ 1.2
Mean value (mm3) 628 + 348* 1021 + 380*
Mean rate of contractility (%) 77.3 + 22.1" 51.14- 18.0"
HEA: hypoechoic area around the gallbladder, PTCCD: percutaneous transhepatic cholecystic
drainage, PTCCSL: percutaneous transhepatic cholecystoscopic lithotomy.
*p<0.01.
TABLE IV Endoscopic findings
Sludge Positive groupn= 15 (%) Negative groupn=24 (%)
Reticular 7 (46) 16 (42)
Granular 3 (20) 5 (13)
Flat (7) 4 (17)
DET 4 (27) 0 (0)
DET: deteriorated.
contractility, calculated by dividing the gallblad-
der area after intramuscular injection of ceruletide
diethylamine by that before injection, was 51% in
the sludge-negative group, indicating normal con-
tractility, and 77% in the sludge-positive group,
indicating decreased contractility. This difference
was significant.
(4) Endoscopic Findings (Table IV)
A DET pattern was found only in the sludge-
positive group. There were other significant
differences between the groups.
DISCUSSION
If not treated properly, acute cholecystitis can
rapidly progress to a serious infection. Emergency
cholecystectomy or PTCCD with antibiotic
treatment has been recommended for acute chole-
cystitis [4-6]. In recent years, laparoscopic
cholecystectomy (LC) has gradually replaced
conventional open surgery in patients with acute
cholecystitis, and some centers perform LC as
soon as the diagnosis is established [7]. Preopera-
tively, however, information on the biliary tract is
often lacking in patients with acute cholecystitis,
and the induction of pneumoperitoneum in the
presence of acute cholecystitis carries the risk of
septicemia. Some reports have therefore recom-
mended against LC in patients with acute chole-
cystitis [8]. Other reports have suggested that
cholecystectomy causes active proliferation of the
colonic mucosa and increases the risk of carcino-
genesis [9]. In place of cholecystectomy, PTCCSL
thus holds much promise as a procedure for stone
removal and the treatment of acute cholecystitis.
After PTCCD, PTCCSL has been reported to
be optimally suited for the treatment of elderly
patients and high-risk patients who cannot toler-
ate open surgery [1]. The authors place a PTCCD
tube in patients with acute cholecystitis to permit
drainage. This promptly improves inflammation,
permits examination of the biliary tract, and facili-
tates formulation of the subsequent therapeutic26 S. OHASHI
policy. I therefore believe that PTCCD should be
performed as soon as a diagnosis of acute
cholecystitis has been established, without an
intervening period of conservative therapy.
The development of ultrasonic equipment and
the availability of improved puncture needles and
indwelling tubes have enabled an enlarged, acutely
inflamed gallbladder to be punctured reliably.
Tube dislodgment, a complication reported early
after the advent of PTCCD, did not occur in any
of our patients, Eric et al., similarly reported that
tube dislodgment occurred in only of 127
patients who underwent percutaneous gallbladder
puncture [10]. PTCCD is therefore considered to
be optimally suited for the treatment of acute
cholecystitis. In addition, since the fistula closes
about week after puncture, the stones could be
removed under PTCCS guidance in all patients
[11]. Complications caused by PTCCSL occurred
in a total of 2 patients (3.8%): one with gallblad-
der bleeding and one with injury to the cystic
duct. Ichikawa et al. reported gallbladder bleed-
ing in three patients (5.8%), but there were no
other serious complications; treatment was there-
fore able to be performed conservatively [1]. EHL
is the most reliable treatment for lithotomy under
endoscopic guidance. PTCCSL is most difficult to
perform when the stone leaves the neck of the
gallbladder and enters the spiral part of the cystic
duct, precluding a direct view on endoscopy. The
injury to the cystic duct described above occurred
while attempting to remove by EHL a stone from
the cystic duct. Endoscopic procedures are espe-
cially difficult to perform in the narrow region
from the neck of the gallbladder to the convo-
luted part of the cystic duct; EHL should there-
fore be performed only when a direct view of the
stone can be obtained. Since the stone is incarcer-
ated, the injured gallbladder mucosa is fragile.
Lithotripsy must be performed with extreme care.
With the exception of this case, stone removal
was successfully accomplished endoscopically in
all other patients. Lithotomy was possible under
direct vision in all patients, but the concurrent
use of extracorporeal shock-wave lithotripsy or
direct litholysis is useful at sites unable to be
viewed directly.
We had expected to observe a wide range of
endoscopic findings on PTCCS because of changes
of the gallbladder mucosa caused by the long-
term presence of one or more stones and changes
due to acute cholecystitis. The basic findings of
the mucosa were therefore evaluated separately
from other findings. Watanabe et al. classified the
surface pattern of the gallbladder mucosa as
reticular, funicular, granular, papillary, or lobular
according to resected specimens ofnormal mucosa,
metaplastic mucosa, and carcinoma [12]. I
modified this system and classified endoscopic
findings of the gallbladder mucosa in acute
cholecystitis as reticular, granular, flat, or DET.
About 56% of the cases had a reticular mucosa,
and there were few cases with a flat or granular
mucosa; most patients had nearly normal endo-
scopic findings. Watanabe et al. reported that
pathological evidence of a reticular pattern of the
mucosa is seen in normal tissue or metaplastic
tissue [12]. Since the reticular mucosa in this
study was in patients with gallbladder stones, the
gallbladder mucosa in this series most likely had
some type of metaplastic changes. In the patients
who were followed up, the granular mucosa had
a homogenous, finely granular appearance, and
there was no evidence of fusion between granules
or of asymmetry. In patients with gallbladder
carcinoma, we have found papillary and nodular
patterns of the mucosa combined with a granular
appearance. Even in areas of granular mucosa,
the granules were irregularly shaped and showed
irregular areas of redness. Cancer could be diag-
nosed on the basis of these findings, as reported
by Inui et al. [13]. The flat mucosa has flattened
reticular sites and resembles the atrophic mucosa
seen in gastritis. Since there are also some areas
of funicular mucosa, the flat mucosa is similar to
the funicular and the flat mucosa described by
Watanabe et al. and it is thought to reflect deteri-
oration of the gallbladder mucosa. A yellowish
white, thick unstructured filamentous structure
with no appreciable signs of a DET pattern of theMANAGEMENT OF ACUTE CHOLECYSTITIS 27
gallbladder mucosa was seen in four patients. These
patients were left untreated despite remarkable
inflammation for a prolonged period or appeared
to have emphysematous cholecystitis, leading to
the development of very severe mucosal necrosis.
Prior reports have described the concurrent
presence of acute cholecystitis and gallbladder
carcinoma [14]. This series also included three
patients (5.6%) who concurrently had cancer. In
patients with cholecystitis the decision whether or
not to preserve the gallbladder depends largely on
the presence or absence of cancer. During the
acute phase of acute cholecystitis, sludge often
accumulates in the gallbladder, and the properties
of the mucosa are indistinct on ultrasonographic
examination. About 74% of early carcinomas of
the gallbladder have been reported to be super-
ficial carcinomas [12]. Since diagnosis is extremely
difficult, carcinomas are often found accidently
on pathological examination of the resected gall-
bladder, particularly when there was evidence of
a protruding lesion on extracorporeal ultrasonog-
raphy. With the use of PTCCD as described
above, acute inflammation can be confined to a
minimum, and accurate diagnosis is possible by
biopsy and examination of the mucosa by PTCCS
and by cytological diagnosis of the bile obtained
from the drainage tube.
In patients who concurrently have cancer,
PTCCS may cause metastasis via the drainage
fistula [15]. I treat the fistula with alcohol in
patients with cancer. Histological studies were
performed in one patient who subsequently under-
went surgery, but there was no evidence of
metastasis. Even in patients who were unable to
undergo surgery, there was no evidence of inva-
sion to the area around the fistula on CT or
extracorporeal ultrasonography.
After PTCCSL, patients are given 600mg/day
ofUDCA to prevent stone recurrence. A previous
study has reported that about week after the
termination of choleretic agents the degree of
cholesterol saturation returns to the pre-treatment
level, which increases the. risk of stone recurrence
[16]. The continuous administration of oral
gallstone-dissolving agents is considered effective
in preventing stone recurrence. Dowling et al.
found that the 12-month rate of recurrence with
oral gallstone dissolving agents ranged from 10%
to 15% [17]. During follow-up, I had only one
case (2.5%) of recurrence, which is clearly low as
compared with previous reports. This patient had
a bilirubin stone, and gallbladder contractility
was low (73%). Acute cholecystitis recurred after
about 10 months. PTCCSL was repeated at the
patient’s request, and the stone was removed. In
such patients who have distinct evidence of low
gallbladder function, the preservation of function
should not be the ultimate goal of treatment, but
this case demonstrates the high acceptance of
PTCCSL.
The mean period of follow-up after PTCCSL
in 40 patients was only about 3.5 years. The
presence of sludge in the gallbladder was an
important factor in predicting the long-term out-
come in these patients. Bernard et al. studied a
series of patients with decreased gallbladder func-
tion who received total parenteral nutrition for
6 months [18]. During follow-up, gallstones formed
only in patients with sludge in the gallbladder;
there was no evidence of stone formation in
patients with no sludge. I divided 39 of patients,
excluding the one with stone recurrence after
PTCCSL, into a sludge-positive group and a
sludge-negative group on the basis of the presence
or absence of ultrasonographic evidence of sludge
and compared their clinical demographic charac-
teristics, clinical signs and symptoms of acute
cholecystitis, ultrasonographic findings of the
abdomen, and endoscopic findings. The mean
period of follow-up was similar in the sludge-
positive group (46 months) and the sludge-nega-
tive group (40 months). There were no significant
differences between the groups in other clinical
characteristics or in the type of gallstone or the
maximum stone diameter. The proportion of
patients receiving choleretic agents was slightly,
but not significantly, higher in the sludge-negative
group, and there was no significant differences in
any clinical characteristic.28 S. OHASHI
As for the clinical signs and symptoms of acute
cholecystitis, there were no significant differences
between the groups in body temperature or
leukocyte count before PTCCD, and the severity
of inflammation was considered similar. There
were also no distinct differences between the
groups with respect to the improvement in symp-
toms after PTCCD or the response to treatment.
In both groups PTCCSL was performed three
times or less in the majority of patients. The only
difference noted was that the period from the
onset of symptoms until PTCCD was 10 days or
more in the sludge-positive group, as compared
with 2.5 days or less in the sludge-negative group;
treatment by PTCCD was clearly started earlier
in the sludge-negative group. Acute cholecystitis
is characterized by acute obstructive cholecysto-
pathy caused by obstruction of the cystic duct or
the neck of the gallbladder. In studies of the time
course of acute cholecystitis, Mutoh et al. found
that congestion and edema of the gallbladder wall
develops 2-4 days after stone impaction and
obstruction [19]. The gallbladder tissue is initially
preserved, but continued obstruction leads to
increased luminal pressure within the gallbladder
and to circulatory failure, which results in tissue
necrosis. After about 5 days, abscess formation
occurs inside the gallbladder as well as around
the gallbladder. In the present study, PTCCD was
performed immediately after diagnosis, and the
mean period from initial examination until
PTCCD was short, especially in the sludge-nega-
tive group. Given that circulatory failure due to
obstruction of the cystic duct is the main feature
of acute cholecystitis, in patients in whom circula-
tory failure responded to early drainage, necrosis
of the gallbladder wall could also be avoided and
the function of the gallbladder could be preserved.
This was apparently responsible for the better out-
come in terms of gallbladder function the sludge-
negative group, in which drainage was performed
earlier than in the sludge-positive group.
When ultrasonograms were compared, there
was no distinct difference in findings before
PTCCD. However, on follow-up examination
after PTCCSL, the mean area had decreased to
628mm
3 in the sludge-positive group, but a normal
area of 1021 mm
3 was maintained in the sludge-
negative group. The mean area after the intra-
muscular injection of ceruletide diethylamine had
decreased to 77.3% of the pre-injection area in the
sludge-positive group, whereas the value remained
within the normal range of 51.1% in the sludge-
negative group. As for ultrasonographic findings
of acute cholecystitis, Guy et al. reported that the
hyperechoic region of the gallbladder wall indi-
cated are as of inflammatory edema and that the
hyperechoic region in the early stage improved
in response to conservative therapy [20]. On the
other hand, similar hyperechoic regions have been
reported to indicate abscess formation, and the
surrounding hyperechoic areas pericystic abscess
formation [21-23]. The presence of these ultra-
sonographic findings indicates a high risk of gan-
grenous cholecystitis. In the present study, good
function was preserved in some patients with
these ultrasonographic findings. The presence of
such findings alone therefore does not provide an
adequate basis for the prediction of gallbladder
function after PTCCSL. Further studies analyzing
the qualitative and quantitative characteristics of
hyperechoic areas around the gallbladder are
required to establish the diagnostic value of
ultrasonography.
On endoscopic examination, the incidences of
reticular, granular, and flat patterns of the gall-
bladder were similar in both the sludge-positive
group and the sludge-negative group. However, a
DET pattern, indicating epithelial loss and the
presence of extensive areas of yellowish white
fibers covering the inside of the lumen, was found
only in the sludge-positive group. These patients
also had decreased contractility, and endoscopic
evidence of a DET pattern is considered charac-
teristic of severe cholecystitis with virtually com-
plete loss of gallbladder function. Since such
cases progress gradually to an atrophic gallblad-
der, a DET pattern is regarded to correspond to
acute phlegmon type or abscess type, as described
by Itoi et al. [24]. These endoscopic findings are
considered to reflect necrosis of all layers of the
gallbladder wall. Because the gallbladder becomesMANAGEMENT OF ACUTE CHOLECYSTITIS 29
atrophic in these patients, there is a low risk of
stone recurrence, and the long-term outcome is
generally good.
The results of this study indicate that the
drainage in patients with acute cholecystitis can
promptly resolve inflammation. In addition, endo-
scopic lithotomy can be performed via the drain-
age fistula to remove gallstones. The presence or
absence of cancer can be concurrently evaluated.
According to this study, gallbladder function did
not recover satisfactorily in the patient who had
evidence of progression to gangrenous cholecys-
titis on ultrasonographic and endoscopic examina-
tions. Therefore in patients with stone recurrence
or repeated episodes of cholecystitis, cholecystec-
tomy will be the treatment of choice. However,
PTCCSL is considered useful in both elderly pati-
ents with serious concurrent conditions as well as
in younger patients. If performed promptly after
the onset of acute cholecystitis, PTCCSL i a safe
technique that can provide contribute signifi-
cantly to the preservation of gallbladder function.
Acknowledgments
The author is grateful to Prof. Tetsu Yamaguchi,
Prof. Yoshihiro Sakai, and Dr. Iruru Maetani,
Lecturer, of the Third Department of Internal
Medicine, Toho University, for their guidance in
this study and review of the manuscript. The
author also sincerely appreciate the help and
cooperation of colleagues in the Third Department
of Internal Medicine, Toho University.
References
[1] Ichikawa, K., Ichikawa, M., Takahashi, S. et al. Percuta-
neous transhepatic cholecystoscopy (PTCCS) for the non-
surgical treatment of acute cholecystitis. J. Biliary Tract
and Pancreas 1992; 13:743-750 (in Japanese).
[2] Inui, K., Nakazawa, S., Naito, Y. et al. Nonsurgical
treatment of cholecystolithiasis with percutaneous transhe-
patic cholecystoscopy. Am. J. Gastroenterology 1988; 83:
1124-1127.
[3] Ichkawa, K., Nakazawa, S., Naitou, Y. et al. Diagnosis of
protuberant lesions of the gallbladder by PTCCS and
PTDCC. J. Biliary Tract and Pancreas 1985; 6:39-44 (in
Japanese).
[4] Addison, N.V. and Fianan, P.J. Urgent and early cholecys-
tectomy for acute gallbladder disease. Br. J. Surg. 1988;
75: 141-143.
[s]
[6]
[7]
[81
[91
[10]
[11]
[12]
[13]
[14]
[15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
Linden, W. and Edlund, G. Early versus delayed chole-
cystectomy. The effect of a change in management. Br. J.
Surg. 1981; 68: 753-757.
Mcsherry, C.K. Cholecystectomy. The gold standard.
Am. J. Surg. 1989; 158: 174-178.
Flowers, J.L., Bailey, R.W., Scovill, W.A. et al. The
baltimore experience with laparoscopic management of
acute cholecystitis. Am. J. Surg. 1991; 161: 388-392.
Idezuki, Y. and Otomo, Y. Laparoscopic cholecystect-
omy Present status and prospect in future. J. Biliary
Tract and Pancreas 1992; 13:1-5 (In Japanese).
Soltero, E., Cruz, N.I., Nazario, C.M. et al. Cholecystec-
tomy and right colon cancer in Puerto Rico. Cancer 1990;
66: 2249-2252.
Eric, V., Horacio, B., Brian, W. et al. Percutaneous gall-
bladder puncture and cholecystostomy. Result, complica-
tions, and caveats for safety. Radiology 1992; 183: 167-170.
Maetani, I., Ohashi, S., Ogawa, S. et al. Percutaneous
cholecystolithotomy for treatment of acute cholecystitis
using PTCCS. Diagnostic Imaging of the Abdomen 1994;
14:224-231 (in Japanese).
Watanabe, H., Kijima, H., Uchida, K. et al. Definition
and morphological characteristics of early carcinoma of
the gallbladder. Stomach and Intestine 1986; 21:483-495
(in Japanese).
Inui, K., Nakazawa, S., Yoshio, J. et al. Cholecystoscopy
and endoscopic ultrasonography. J. Biliary Tract and
Pancreas 1992; 13:143-148 (in Japanese).
Douglas, A. Person: Carcinoma of the gallbladder pre-
senting as acute cholecystitis and leading to a missed
clinical and pathologic diagnosis. Am. J. Surg. 1964; 108:
95-97.
Juan, A.O., Ernest, J.R., David, B.F. et al. Extension of
neoplasm along the tract of a transhepatic tube. Am. J.
Radiology 1980; 135: 841-842.
Iser, J.H., Murphy, G.M. and Dowling, H. Speed of
change in bilialy lipids and bile acids with choledeoxy-
cholic acid. Is intermittent therapy feasible? Gut 1977; 18:
7-15.
Dowling, R.H., Gleeson, D.C., Hood, K.A. et al. Gall-
stone recurrence and postdissolution management. Bile
acids and the Liver. MPT press limited. 1986: 355-367.
Bernard, M., Chistian, B., Francis, K. et al. Dose total
parenteral nutrition induce gallbladder sludge formation
and lithiasis. Gasteroenterology 1983; 84: 1012-1019.
Mutou, Y., Uchida, M., Waki, S. et al. Clinicophatholo-
gical study of obstructive cholecystpathy Relationship
of gallbladder lesion to clinical symptom. J. Japan
Surgical Society 1981; 14:672-677 (in Japanese).
Guy, J.F., Marc, C., Albert, L. et al. Gallbladder wall
sonolucency in acute cholecystitis. Radiology 1979; 133:
429-433.
Takada, T., Yasuda, H., Uchiyama, K. et al. Perichole-
cystic abscess-Classification of US findings to determine
the proper therapy. Radiology 1989; 172: 693-697.
Bergman, A.B., Neiman, H.L. and Kraut, B. Ultrasonog-
raphic evaluation of pericholecystic abscesses. A. J. R.
1979; 132: 201-203.
Crade, M., Taylor, K.J.W., Rosenfield, A.T. et al.
Ultrasonic imaging of pericholecystitic inflammation.
J. A. M. A. 1980; 15: 708-709.
Itoi, T., Watanabe, H., Takei, K. et al. Pathology of the
acute cholecystitis Its classification and transition ofgross
type and its differentiation from carcinoma. Diagnostic
Imaging of the Abdomen 1994; 14:143-156 (in Japanese).